{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T06:38:48Z","timestamp":1697611128822},"reference-count":102,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,3,28]],"date-time":"2002-03-28T00:00:00Z","timestamp":1017273600000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Med Austriaca"],"published-print":{"date-parts":[[2002,2]]},"abstract":"<jats:p><jats:bold>Summary:<\/jats:bold> Systemic Sclerosis (SSc) or Scleroderma is a generalized autoimmune disease with variable involvement of the skin and major organs. Etiology and pathogenesis are still largely unknown, but a variety of humoral and cellular autoimmune phenomena can be observed, and a pivotal role of T lymphocytes in SSc pathogenesis is postulated. The rarity of the disease, the wide spectrum of clinical manifestations and severity as well as a variable course render therapy in SSc a major challenge. In view of the immunopathogenesis of SSc, many (presumed) immunomodulatory agents have been used, but no single agent has been proven to be convincingly effective. Trials with extracorporeal therapies (such as photopheresis, plasmapheresis) or even stem cell transplantation are in progress. \u2028In contrast to the hitherto unsuccessful therapeutic approaches for the overall disease course, some life\u2010threatening organ manifestations can often be treated successfully, e.g. interstitial pneumonitis with i.v. cyclophosphamide and scleroderma renal crisis with ACE inhibitors and haemodialysis, respectively. Furthermore, pharmacological and supportive treatment of Raynaud's phenomenon and gastrointestinal involvement can alleviate the burden of the disease. Current therapeutic options as well as hitherto investigated immunomodulators are reviewed in this article.<\/jats:p>","DOI":"10.1046\/j.1563-2571.2002.01038.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T01:52:35Z","timestamp":1047347555000},"page":"14-19","source":"Crossref","is-referenced-by-count":6,"title":["Current Treatment Options in Systemic Sclerosis (Scleroderma)"],"prefix":"10.1111","volume":"29","author":[{"given":"G.\u2003H.","family":"Stummvoll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,3,28]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/07853890.1993.12088576","article-title":"Activation of dermal connective tissue in scleroderma","volume":"29","author":"Kahari VM","year":"1993","journal-title":"Ann Med"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118851"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70296-9"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/08830189509056716"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270607"},{"key":"e_1_2_8_7_2","first-page":"264","article-title":"Lymphocyte phenotyping in systemic sclerosis: a flow cytometry analysis of lymphocytes in bronchoalveolar lavage fluid","volume":"29","author":"Domagala KJ","year":"1997","journal-title":"Anal Quant Cytol Histol"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.95.08020266"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.1.40"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.12.1341"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(90)90147-I"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.11.5545"},{"key":"e_1_2_8_13_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/03009742.1998.11720698","article-title":"Microchimerism and the causation of scleroderma","volume":"29","author":"Nelson JL","year":"1998","journal-title":"Scand J Rheumatol Suppl"},{"key":"e_1_2_8_14_2","first-page":"368","article-title":"Soluble interleukin\u20102 receptor, interleukin\u20102 and interleukin\u20104 in sera and supernatants from patients with progressive systemic sclerosis","volume":"29","author":"Famularo G","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350111"},{"key":"e_1_2_8_16_2","first-page":"328","article-title":"Elevated serum levels of interleukin 4 (IL\u20104), IL\u201010, and Il\u201013 in patients with systemic sclerosis","volume":"29","author":"Hasegawa M","year":"1997","journal-title":"J Rheumatol"},{"key":"e_1_2_8_17_2","first-page":"663","article-title":"Elevated serum tumor necrosis factor\u2010alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis","volume":"29","author":"Hasegawa M","year":"1997","journal-title":"J Rheumatol"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1994.tb01488.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.163.10.5693","article-title":"Anti\u2010TGF\u2010beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft\u2010versus\u2010host disease: a model for human scleroderma","volume":"29","author":"McCormick LL","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370218"},{"key":"e_1_2_8_21_2","first-page":"1876","article-title":"Elevated levels of platelet derived growth factor and transforming growth factor\u2010beta 1 in bronchoalveolar lavage fluid from patients with scleroderma","volume":"29","author":"Ludwicka A","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350307"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199800001-00157"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01115.x"},{"key":"e_1_2_8_25_2","first-page":"273","volume-title":"Primer on the rheumatic diseases. 11th edition","author":"Steen VD","year":"1997"},{"key":"e_1_2_8_26_2","first-page":"535","volume-title":": Systemic sclerosis. 1st edition","author":"Seibold J","year":"1996"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-5-652"},{"key":"e_1_2_8_29_2","first-page":"1496","article-title":"A 15\u2010year prospective study of treatment of rapidly progressive systemic sclerosis with D\u2010penicillamine","volume":"29","author":"Jimenez SA","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02030514"},{"key":"e_1_2_8_31_2","first-page":"1435","article-title":"D\u2010penicillamine treatment in systemic sclerosis","volume":"29","author":"Steen V","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70307-0"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7"},{"key":"e_1_2_8_34_2","first-page":"2493","article-title":"In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D\u2010penicillamine","volume":"29","author":"Katayama Y","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90146-4"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000169183"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.97.6.690"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320512"},{"key":"e_1_2_8_39_2","first-page":"527","article-title":"Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis","volume":"29","author":"Fuchs D","year":"1986","journal-title":"Clin Rheumatol"},{"key":"e_1_2_8_40_2","first-page":"383","article-title":"Efficacy of cyclosporin A in systemic sclerosis","volume":"29","author":"Gisslinger H","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360113"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb07290.x"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.8.865"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.1.90"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.11.926"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910213411703"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351005"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80150-0"},{"key":"e_1_2_8_49_2","first-page":"831","article-title":"Interferon\u2010gamma induced exacerbation of systemic lupus erythematosus","volume":"29","author":"Machold KP","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_8_50_2","first-page":"1621","article-title":"Induction of systemic lupus erythematosus by interferon\u2010gamma in a patient with rheumatoid arthritis","volume":"29","author":"Graninger WB","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90554-8"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-12-200006200-00004"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370518"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100670050138"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320911"},{"key":"e_1_2_8_57_2","first-page":"1113","volume-title":"Textbook of Rheumatology. 4th edition","author":"Seibold JR","year":"1993"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370903"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70077-7"},{"key":"e_1_2_8_60_2","first-page":"99","article-title":"Clinical and mechanistic aspects of photopheresis","volume":"29","author":"Van IH","year":"1997","journal-title":"J Photochem Photobiol B"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70212-X"},{"key":"e_1_2_8_62_2","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood.V92.9.3098","article-title":"Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft\u2010versus\u2010host disease","volume":"29","author":"Greinix HT","year":"1998","journal-title":"Blood"},{"key":"e_1_2_8_63_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archderm.1992.01680130051005","article-title":"Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial","volume":"29","author":"Rook AH","year":"1992","journal-title":"Arch Dermatol"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050166"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017927"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00066.x"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.12.1276"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780240903"},{"key":"e_1_2_8_69_2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/039139888300600608","article-title":"Treatment of progressive systemic sclerosis with plasma exchange. Seven cases","volume":"29","author":"Guillevin L","year":"1983","journal-title":"Int J Artif Organs"},{"key":"e_1_2_8_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)64864-7"},{"key":"e_1_2_8_71_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar102"},{"key":"e_1_2_8_72_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.6.577"},{"key":"e_1_2_8_73_2","first-page":"493","article-title":"The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study","volume":"29","author":"Finch MB","year":"1986","journal-title":"Clin Rheumatol"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T"},{"key":"e_1_2_8_75_2","unstructured":"PopeJ FenlonD ThompsonA SheaB FurstD WellsG: Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis. Cochrane Database Syst Rev2000;(2):CD000953."},{"key":"e_1_2_8_76_2","first-page":"137","article-title":"Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon","volume":"29","author":"Bartolone S","year":"1999","journal-title":"Minerva Cardioangiol"},{"key":"e_1_2_8_77_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6673.561"},{"key":"e_1_2_8_78_2","first-page":"1407","article-title":"Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis","volume":"29","author":"Wigley FM","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_8_79_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009748909099925"},{"key":"e_1_2_8_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.9.1038"},{"key":"e_1_2_8_81_2","first-page":"269","article-title":"Adventitial stripping: a digit saving procedure in refractory Raynaud's phenomenon","volume":"29","author":"Yee AM","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_8_82_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-199909000-00012"},{"key":"e_1_2_8_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/28.6.553"},{"key":"e_1_2_8_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370902"},{"key":"e_1_2_8_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1991.tb05593.x"},{"key":"e_1_2_8_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00241-7"},{"key":"e_1_2_8_87_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607253350416"},{"key":"e_1_2_8_88_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111213252102"},{"key":"e_1_2_8_89_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.3.265"},{"key":"e_1_2_8_90_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-5-352"},{"key":"e_1_2_8_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351117"},{"key":"e_1_2_8_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340211"},{"key":"e_1_2_8_93_2","first-page":"1","article-title":"Epidemiology and natural history of systemic sclerosis","volume":"29","author":"Steen VD","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"e_1_2_8_94_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.57.11.682"},{"key":"e_1_2_8_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90732-X"},{"key":"e_1_2_8_96_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.2.8049830"},{"key":"e_1_2_8_97_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-6-199409150-00003"},{"key":"e_1_2_8_98_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199912)42:12<2638::AID-ANR20>3.0.CO;2-X"},{"key":"e_1_2_8_99_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199803)41:3<466::AID-ART13>3.0.CO;2-O"},{"key":"e_1_2_8_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(97)00930-2"},{"key":"e_1_2_8_101_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.105.3.837"},{"key":"e_1_2_8_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(00)00349-1"},{"key":"e_1_2_8_103_2","volume-title":"Lecture at the 65th Annual Scientific Meeting of the American College of Rheumatology","author":"Seibold J","year":"2001"}],"container-title":["Acta Medica Austriaca"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1563-2571.2002.01038.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1563-2571.2002.01038.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T14:31:48Z","timestamp":1697553108000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1563-2571.2002.01038.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["10.1046\/j.1563-2571.2002.01038.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1563-2571.2002.01038.x","archive":["Portico"],"relation":{},"ISSN":["0303-8173","1563-2571"],"issn-type":[{"value":"0303-8173","type":"print"},{"value":"1563-2571","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}